+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Topoisomerase-1 and thymidylate synthase primary tumor expression as prognostic and predictive factors for response to CPT-11 in advanced colorectal cancer patients



Topoisomerase-1 and thymidylate synthase primary tumor expression as prognostic and predictive factors for response to CPT-11 in advanced colorectal cancer patients



European Journal of Cancer 37(Suppl. 6): S308




(PDF emailed within 1 workday: $29.90)

Accession: 035963042

Download citation: RISBibTeXText


Related references

Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients. International Journal of Cancer 111(2): 252-258, 2004

Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment. Zhonghua Zhong Liu Za Zhi 27(5): 312-315, 2005

Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer. Oncology Reports 14(3): 657-662, 2005

Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer. Anticancer Research 30(2): 645-651, 2010

Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer. European Journal of Surgical Oncology 31(8): 863-868, 2005

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. British Journal of Cancer 82(3): 560-567, 2000

Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fluoropyrimidine-based chemotherapy: evidence from 24 studies. International Journal of Cancer 123(10): 2384-2389, 2008

Significance of differential expression of thymidylate synthase in normal and primary tumor tissues from patients with colorectal cancer. Journal of Hematology and Oncology 4: 33, 2011

Thymidylate synthase (TS) protein expression as a prognostic factor in advanced colorectal cancer: a comparison with TS mRNA expression. Hepato-Gastroenterology 59(116): 1059-1062, 2012

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. Journal of Clinical Oncology 20(7): 1735-1743, 2002

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. Journal of Clinical Oncology 20(7): 1721-1728, 2002

Studying the predictive/prognostic role of thymidylate synthase genotypes in patients with colorectal cancer: Is one polymorphism enough?. Journal of Clinical Oncology 23(28): 7230-1; Author Reply 7231, 2005

Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. Clinical Cancer Research 9(2): 792-801, 2003

Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancer. Annals of Oncology 15(1): 55-58, 2004

Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancer. Annals of Oncology 15(1): 55-58, 2003